6143 POSTER Study 20050203/PRIME – Effect of Post-Progression Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody (mAb) Therapy in Patients With Wild-Type (WT) KRas Metastatic Colorectal Cancer (mCRC)

✍ Scribed by Siena, S.; Douillard, J.Y.; Cassidy, J.; Tabernero, J.; Burkes, R.; Barugel, M.E.; Humblet, Y.; Cunningham, D.; Yu, H.; Krishnan, K.

• Book ID: 122863142
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 45 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)71788-9